von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic SyndromeMiha Furlan, Bernhard Lämmle, I. Scharrer et al.|New England Journal of Medicine|1998Cited by 1.7k
Increased fetal loss in women with heritable thrombophiliaF E Preston, F Van Der Meer, FR Rosendaal et al.|The Lancet|1996Cited by 677
Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia ARichard S. Schwartz, Randy Allred, Charles F. Abildgaard et al.|New England Journal of Medicine|1990Cited by 266
Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin DeficiencyHester H. van Boven, David A. Lane, Pieter H. Reitsma et al.|Thrombosis and Haemostasis|1996Cited by 239
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)C.Y. VOSSEN, Frits R. Rosendaal, J. Conard et al.|Journal of Thrombosis and Haemostasis|2005Cited by 202